4//SEC Filing
PERRY GREGORY D 4
Accession 0001415889-23-010290
CIK 0001479419other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:00 PM ET
Size
12.0 KB
Accession
0001415889-23-010290
Insider Transaction Report
Form 4
PERRY GREGORY D
Director
Transactions
- Award
Common Stock
2023-06-22+5,856→ 8,394 total - Award
Common Stock
2023-06-22+1,100→ 9,494 total - Award
Stock Option (right to buy)
2023-06-22+7,808→ 7,808 totalExercise: $14.56Exp: 2033-06-21→ Common Stock (7,808 underlying) - Award
Stock Option (right to buy)
2023-06-22+2,500→ 2,500 totalExercise: $14.56Exp: 2033-06-21→ Common Stock (2,500 underlying)
Footnotes (6)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 1/3 of the shares underlying the RSUs on June 22, 2024, as to 1/3 of the shares underlying the RSUs on June 22, 2025 and as to the final 1/3 of shares underlying the RSUs on June 22, 2026.
- [F2]Includes 8,394 unvested RSUs.
- [F3]Grant of RSUs under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023.
- [F4]Includes 9,494 unvested RSUs.
- [F5]This option was granted on June 22, 2023 and vests over four years beginning on the vesting commencement date of June 22, 2023, with 25% of the shares underlying the option vesting on June 22, 2024, and an additional 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter.
- [F6]This option was granted on June 22, 2023 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001236371
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:00 PM ET
- Size
- 12.0 KB